Evidence-based prescription of antibiotics in urology: A 5-year review of microbiology

BJU International

Volumn 104, Issue 6, 2009, Pages 760-764

  Dasgupta, Ranan ^a   Sullivan, Rebecca ^a   French, Gary ^b   O'Brien, Timothy ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Resistance; Urology

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; PENICILLIN G; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CYSTOSCOPY; DRUG RESISTANCE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EVIDENCE BASED PRACTICE; HUMAN; KLEBSIELLA; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; URINARY TRACT INFECTION; URINE CULTURE; UROSEPSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; INFECTION CONTROL; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 69249121658     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08779.x     Document Type: Article

References (15)

1. Naber KG, Bishop MC, Bjerklund-Johansen TE et al. Perioperative antibacterial prophylaxis in urology. EAU Guidelines on the Management of Urinary and Male Genital Tract Infections, EAU, 2006, pp. 100 109
2. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008 153 (Suppl. 1 1 9
3. Bootsma AM, Laguna MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 2008 54 : 1270 1286
4. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 2006 98 : 1075 1079
5. Thiruchelvam N, Yeoh SL, Keoghane SR. MRSA in urology: a UK hospital experience. Eur Urol 2006 49 : 896 899
6. Kashanian J, Hakimian P, Blute M et al. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 2008 102 : 1634 1637
7. Vromen M, van der Ven A, Knols A, Stobberingh EE. Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrobial Chemother 1999 44 : 113 116
8. Kurutepe S, Surucuoglu S, Sezgin C, Gazi G, Gulay M, Ozbakkalouglu B. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jap J Inf Dis 2005 58 : 159 161
9. DasGupta R, French G, Glass JM. Multi-resistant Pseudomonas aeruginosa outbreak in an endourology unit. Eur Urol 2008 53 : 1009
10. Wagenlehner F, Stower-Hoffmann J, Schneider-Brachert W, Naber KG, Lehn N. Influence of a prophylactic dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 2000 15 : 207 211
11. Johnson MI, Merrilees D, Robson WA et al. Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int 2007 100 : 826 829
12. Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991 35 : 1284 1290
13. Cross AS, Opal S, Kopecko D. Progressive increase in antibiotic resistance of gram negative bacterial isolates. Walter Reed Hospital, 1976 to 80: specific analysis of gentamicin, tobramycin and amikacin resistance. Arch Int Med 1983 143 : 2075 2080
14. Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J et al. Control of emergence of multi-resistant Gram-negative bacilli by exclusive use of amikacin. Am J Med 1986 80 : 71 5
15. Acar JA, Goldstein FW, Menard R, Bleriot JP. Strategies in aminoglycoside use and impact on resistance. Am J Med 1986 80 : 82 7